step 2 semaglutide 2.4 mg weekly semaglutide Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial-150cent Semaglutide 2.4 mg for the

One uncommon side effect is gastroparesisdelayed gastric emptying

Adipose tissue is not merely an energy store but an active endocrine organ producing pro-inflammatory mediators called adipokines

Cuando la actividad est alterada, puede ocurrir lo contrario

What is Obesity: Everything You Need to Know Obesity has become a significant public health concern in the UK, impacting millions of adults and children, with countless people struggling

If this sounds like you, click here to see how it all works.

Today, patients have more options than ever, including gastric sleeve, gastric bypass, duodenal switch, and single-anastomosis procedures